60% off Profit Pro - Limited Time Offer!
4.12BUSD
See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US0008991046
CUSIP
000899104
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
64.48
PEG Ratio
-
Book Value
0.98
Dividend Share
-
Dividend Yield
-
Earnings Share
0.27
Wall Street Target Price
24.618
EPS Estimate Current Year
0.564
EPS Estimate Next Year
0.7375
EPS Estimate Current Quarter
0.13
EPS Estimate Next Quarter
0.14
Most Recent Quarter
-
Revenue TTM
382,808,992
Gross Profit TTM
35,265,157
EBITDA
125,894,000
Profit Margin
17.80%
Return On Assets TTM
19.89%
Return On Equity TTM
35.55%
Revenue Per Share TTM
1.661
Qtly Revenue Growth YOY
78.10%
Diluted Eps TTM
0.27
Qtly Earnings Growth YOY
1400.00%
Trailing PE
64.48
Forward PE
19
Price Sales TTM
10.7509
Price Book MRQ
17.7479
Enterprise Value Revenue
10
Enterprise Value EBITDA
41
88.70
1.04%630.00
0.00%173.50
0.00%198.28
0.00%112.38
-1.34%99.02
-0.96%711.05
-0.48%406.10
-0.45%243.01
-0.18%629.00
-0.16%